InnAccel
InnAccel is a Bangalore-based medical technology company developing patented critical care, neonatal, and maternal health devices (VapCare, Fetal Lite, SAANS) for hospitals and government health systems in India and other emerging markets, combining direct sales with grant-backed and donor-funded large-scale deployments.
- Company typePrivate
- Founded2014
- HeadquartersBangalore, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What InnAccel does
InnAccel Technologies Private Limited is a Bangalore-based medical device company founded in 2014 that designs, develops, and commercializes patented medical technologies for critical care, neonatology, and maternal health, with an explicit focus on resource-limited emerging markets. Its portfolio spans three product platforms: VapCare, an automated secretion management and oral hygiene system for ventilated ICU patients designed to reduce ventilator-associated pneumonia; Fetal Lite, an AI-powered wireless fetal heart rate monitor using fetal ECG/EMG signal extraction for intrapartum care; and SAANS, a portable, infrastructure-independent multi-therapy neonatal breathing support system offering Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes in a single device with battery backup. These platforms are built on a Product Engineering and Development (PED) methodology that originated in clinical immersion and needs identification in partner hospitals.
The business operates a hybrid commercialization model combining direct enterprise sales (field Application Specialists in Bangalore, New Delhi, and Patna conducting hospital demonstrations, installations, and training) with public-sector and donor-funded deployments. Notable deployments include 300+ SAANS devices across 30+ government hospitals in Assam (funded by USAID and the Bill & Melinda Gates Foundation in partnership with C-CAMP), an IFC-funded deployment at Hallelujah General Hospital in Ethiopia, and a NARAYANA Health Bangalore clinical trial for VapCare. Direct revenue from medical device sales (hardware) is supplemented by research grants from BIRAC, the Millennium Alliance, the Lemelson Foundation, and other donors, plus pricing is quote-based rather than publicly disclosed. Multi-jurisdictional regulatory clearance is significant: Indian CDSCO across all three core products, U.S. FDA and EU CE for VapCare, EU CE and Indian CDSCO for Fetal Lite, and USFDA 510(k) clearance for SAANS secured in January 2026.
Customer concentration is split across state-level public health systems, international donor agencies, NGOs (I-DO, Infosys Foundation, American India Foundation, ACT), and a long tail of more than 300 hospitals in India and abroad. The company maintains a relatively small team (11–50 employees) backed by an institutional roster including Siraj Dhannani (CEO, ex-PharmARC/IQVIA), A. Vijayrajan (CTO, ex-GE Medical Systems, Wipro Health Sciences, HP), and Shaunak Patel (CCO, ex-J&J Medical India, L.E.K.). Awards include Modi Prix Galien India 2025, Bengaluru Tech Summit Innovator of the Year 2025, MIT Solve Global Health Equity Winner 2024, Gates Foundation recognition, WHO Compendium inclusion 2022, and CES Global Women's HealthTech Award 2021.
InnAccel firmographics
Firmographics- Name
- InnAccel
- Legal name
- InnAccel Technologies Private Limited
- Website
- https://innaccel.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- InnAccel is a Bangalore-based medical technology company developing patented critical care, neonatal, and maternal health devices (VapCare, Fetal Lite, SAANS) for hospitals and government health systems in India and other emerging markets, combining direct sales with grant-backed and donor-funded large-scale deployments.
- Ownership category
- akta.pro rank
InnAccel industry classification
Industry- Product category
- Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE)
- akta.pro secondary industries
- Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC)
Keywords
Where InnAccel is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
InnAccel business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: Sale of medical devices including VapCare, Fetal Lite, and Saans to hospitals, healthcare institutions, and public health systems. Products sold directly to healthcare providers with installation, training, and technical support services.
- Public Health System Deployments: Large-scale deployments funded by government health departments, international donors (USAID, Gates Foundation), and CSR programs. State-level implementations in Assam and Rajasthan represent significant revenue streams.
- Research Grants and Funding: Grant funding from organizations including BIRAC Product Commercialization Program, Millennium Alliance, Lemelson Foundation, and international donors for R&D and deployment projects.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | No public pricing available |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
InnAccel product offering
Product offeringCore offering
InnAccel designs, develops, manufactures, and commercializes patented medical devices for critical care, obstetrics, and neonatal/pediatric care in emerging markets. Its core product portfolio comprises VapCare (automated secretion/oral hygiene management for ventilated ICU patients), Fetal Lite (AI-powered fetal heart rate monitor using ECG signal extraction), and SAANS (multi-therapy, infrastructure-independent neonatal breathing support device with Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes). The company sells directly to hospitals, public health systems, NGOs, and international organizations, and supports deployments with installation, training, and ongoing technical service.
Product overview
InnAccel is a medical device company offering a portfolio of three core patented technologies addressing critical unmet needs in healthcare. VapCare provides automated oral hygiene management for ventilated ICU patients to prevent ventilator-associated pneumonia. Fetal Lite offers AI-powered wireless fetal monitoring using ECG signal extraction technology for mothers during labor. SAANS delivers multi-therapy breathing support (Bubble CPAP, nasal CPAP, HFNC, resuscitation) for neonates and pediatric patients in a single portable device. The product ecosystem spans critical care, maternal health, and neonatal care, with all products designed for accessibility in resource-limited settings.
Differentiator
Problem solved
Functional benefit
Brands
- VapCare: Automated and intelligent secretion management and oral hygiene system for ventilated ICU patients. First-in-the-world automated system addressing Ventilator Associated Pneumonia (VAP).
- Fetal Lite
- SAANS
Products and services
- VapCare First-in-the-world automated secretion management and oral hygiene system for ventilated ICU patients. Automates airway suctioning and oral lavage to ensure consistent compliance with infection prevention protocols, reducing Ventilator-Associated Pneumonia (VAP) risk. For hospital ICUs and critical care providers.
- Fetal Lite AI-powered wireless fetal monitoring system based on fetal ECG signal extraction technology. Designed for mothers in labor or post 36 weeks of gestation, measures fetal heart rate, maternal heart rate, and uterine activity with AI-driven risk classification for fetal distress. For obstetricians, labor and delivery wards, and antenatal care units.
- SAANS Intelligent, infrastructure-independent, multi-therapy breathing support system for neonatal and pediatric patients. Provides Bubble CPAP, nasal CPAP, HFNC therapy, and resuscitation in a single portable device with in-built air-oxygen blender, sensors for flow/pressure/FiO2 monitoring, and 6-hour battery backup. USFDA 510(k) cleared. For NICUs, PICUs, labor rooms, stabilization units, and transport settings.
Quantifiable outcome
- 82% success rate in IFC-funded Saans deployment at Hallelujah General Hospital, Addis Ababa, avoiding invasive mechanical ventilation
- +4 more outcomes
Companies that use InnAccel
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
InnAccel technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
InnAccel partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Infosys FoundationcorePartnership with Infosys Foundation and C-CAMP on Project Early Life, aimed at improving healthcare for expectant mothers and newborns across Karnataka.
- UNITAID / World Health OrganizationminorSaans acknowledged by UNITAID (WHO-hosted organization) in connection with its potential to address neonatal respiratory distress in low-resource settings.
- C-CAMP (Centre for Cellular and Molecular Platforms)coreCollaboration on Project SAANS Assam, a state-wide deployment of 300+ Saans devices across 30+ hospitals covering all NICUs in Assam's State Government health system. Funded by USAID and Bill & Melinda Gates Foundation.
- Indigenous Development Organization (I-DO)coreNGO partnership for Fetal Lite deployment in Mobile Medical Units serving tribal populations in Kothagudem district, Telangana/Chhattisgarh border area. Covers 2300 tribal members in 18 villages.
- International Finance Corporation (World Bank Group)coreIFC-funded Saans deployment at Hallelujah General Hospital in Addis Ababa, Ethiopia showing 82% success rate in clinical outcomes.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
InnAccel competitors and assessment
Company assessmentBroad incumbents
- Fisher & Paykel Healthcare: New Zealand-based global leader in respiratory care, including neonatal CPAP, HFNC, and humidification systems. Directly competes with SAANS in the neonatal respiratory support category, with established hospital distribution and significant R&D resources.
- Dräger: German medical technology company with a strong neonatal and respiratory care portfolio, including Babylog CPAP and ventilation systems. Competes with SAANS in the neonatal respiratory support category, and with VapCare in the ICU ventilation accessories space.
- Philips: Global medtech incumbent with the Avalon fetal/maternal monitor product line, a primary competitor to Fetal Lite in obstetrics. Has broad distribution and clinical relationships in Indian and emerging market hospitals where InnAccel also sells.
- GE HealthCare: Global medtech leader in fetal monitoring (Corometrics), maternal care, and patient monitoring. InnAccel's CTO A. Vijayrajan is a former GE Medical Systems executive, and the company competes with GE in fetal and ICU monitoring categories.
Regional players
- Phoenix Medical Systems: India-based manufacturer of neonatal and maternal care equipment including phototherapy, warmers, and CPAP. Comparable to InnAccel in serving Indian hospital customers with neonatal devices, with overlapping product categories and distribution channels.
Direct peers
- Monica Healthcare: UK-based company specializing in fetal ECG monitoring technology (acquired by GE). Most direct technology peer to Fetal Lite, as both use fetal ECG signal extraction for fetal heart rate monitoring, validating the technical approach.
- Neopenda: US/Kenya-based startup developing wearable vital signs monitors for newborns in resource-limited hospitals. Comparable to InnAccel in developing affordable, infrastructure-independent neonatal monitoring devices for emerging markets with grant-funded deployment models.
- Bempu Health: India-based medical device startup that developed a continuous temperature monitoring bracelet for newborns to detect hypothermia. Comparable to InnAccel in being a Bangalore-based, impact-focused neonatal device company addressing high-mortality conditions in low-resource settings.
- Embrace Innovations: India/US-based social enterprise that developed the Embrace infant warmer for emerging markets, addressing neonatal hypothermia. Highly comparable to InnAccel as a mission-driven, emerging-market-focused neonatal medical device innovator with similar GTM and impact-funder profile.
Emerging players
- Mindray: China-based global medical device company with growing presence in patient monitoring, neonatal care, and emerging markets. Competes with InnAccel in low-cost emerging market segments with broader product portfolios and aggressive pricing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
InnAccel social profiles
Digital presenceInnAccel compliance and trust
Trust signalCompliance7 records
InnAccel financial estimates
Financial estimateRevenue estimate
Valuation estimate
InnAccel leadership team
Management profileNumber of profiles
Profiles8 records
InnAccel funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InnAccel M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InnAccel
What does InnAccel do?
InnAccel designs, develops, manufactures, and commercializes patented medical devices for critical care, obstetrics, and neonatal/pediatric care in emerging markets. Its core product portfolio comprises VapCare (automated secretion/oral hygiene management for ventilated ICU patients), Fetal Lite (AI-powered fetal heart rate monitor using ECG signal extraction), and SAANS (multi-therapy, infrastructure-independent neonatal breathing support device with Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes). The company sells directly to hospitals, public health systems, NGOs, and international organizations, and supports deployments with installation, training, and ongoing technical service.
Is InnAccel a public or private company?
InnAccel is a private company. It is classified as venture growth investor backed and is currently operating.
When was InnAccel founded?
InnAccel was founded in 2014. It employs 11 to 50 people.
Where is InnAccel based?
InnAccel is headquartered in Bangalore, India, in the Asia region.
How does InnAccel make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are public Health System Deployments and research Grants and Funding.
Who are InnAccel's main competitors?
Broad incumbents on record are Fisher & Paykel Healthcare, Dräger, Philips and GE HealthCare. Phoenix Medical Systems is listed as a regional player. Direct peers are Monica Healthcare, Neopenda, Bempu Health and Embrace Innovations. Mindray is listed as an emerging player.
Does InnAccel have an API?
No public API is recorded for InnAccel.
What industry is InnAccel in?
InnAccel's product category is Medical Devices. Its primary akta.pro industry code is HLAHAGAE, Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories), with a secondary code of HSABAKAD, Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers). Its NAICS code is 334510 and its SIC code is 3841.